:::

詳目顯示

回上一頁
題名:女性嚼食檳榔非飲酒者之肝硬化勝算比高於男性
作者:朱裕華
作者(外文):CHU, YU-HUA
校院名稱:亞洲大學
系所名稱:健康產業管理學系健康管理組
指導教授:藍守仁
學位類別:博士
出版日期:2018
主題關鍵詞:肝硬化檳榔非飲酒者公共衛生台灣cirrhosisbetel nutnon-alcohol drinkerpublic healthTaiwan
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:8
背景與目的:
飲酒者中嚼食檳榔與肝硬化的已有明確的相關。 然而,很少有研究探討非飲酒者的嚼食檳榔與肝硬化是否有相關存在。 本研究目的是探討非飲酒者的嚼食檳榔和肝硬化間勝算比的相關。
材料與方法:
本研究回顧分析了2012年成人預防醫療服務和台灣國民健康保險研究數據庫的數據。 參與者的信息包括體檢和生活方式,以及實驗室檢查的數據。 嚼食檳榔者分為三類:從不,偶爾和常常嚼食檳榔。 採用國際疾病分類第九版臨床修改(ICD-9-CM)診斷疾病。 最初2012年收集成人免費預防醫療服務的1,573,024名40歲以上的成年人。 但是,只有1,065,246人被納入分析。 統計分析採用卡方檢定和邏吉斯迴歸分析。
結果:
經多變量分析調整後,兩性的肝硬化和嚼食檳榔存在顯著的相關性(p趨勢檢定<0.0001)。 女性嚼食檳榔者的肝硬化危險性高於男性。 偶爾和常常嚼食檳榔女性肝硬化的勝算比分別為2.91(95%C.I.:1.75-4.83); 3.06(95%C.I.:1.69-5) 。 但是,在偶爾和常常檳榔
嚼食的男的勝算比分別是1.76(95%C.I.:1.47-2.10) 和2.32 (95%C.I.:1.90-2.85) 。
結論:
本研究結果說明,在非飲酒者男性和女性中,嚼食檳榔和肝硬化有顯著的相關性。然而,女性肝硬化的勝算比男性高。
Background and Aim:
The association of betel nut with liver cirrhosis among alcohol drinkers has been clearly shown. However, very scare studies have shown such an association among non-alcohol drinkers. The aim of this study was to assess the relationship between betel nut chewing and cirrhosis among non-alcohol drinkers.
Materials and Methods:
This study retrospectively analyzed data retrieved from the 2012 Adult Preventive Medical Services and the National Health Insurance Research Datasets in Taiwan. Participants’ information included physical examination and lifestyle, alongside laboratory tests. Betel nut chewers were grouped into three categories: never, occasional and frequent. Diseases were diagnosed using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Initially, 1573024 adults aged 40 years and above who engaged in the free adult preventive medical services in 2012 were recruited. However, only 1065246 of them were included in the analysis. Chi-square test and logistic regression were used for the analyses.
Results:
After multivariable adjustments, there were significant relationships between cirrhosis and betel nut chewing in both gender (p-trend < 0.0001).The risk of cirrhosis was greater in females than males. The odds ratio of cirrhosis in occasional and frequent female chewers were respectively 2.91; 95% C.I: 1.75–4.83 and 3.06; 95% C.I: 1.69–5. However, they were 1.76; 95% C.I: 1.47–2.10 and 2.32; 95% C.I: 1.90–2.85 in occasional and frequent male chewers respectively.
Conclusions:
This study demonstrated significant relationships between betel nut chewing and cirrhosis in both male and female non-alcohol drinkers. The risk of cirrhosis was greater in female than male chewers.
References

Ashley, M. J., Olin, J. S., le Riche, W. H., Kornaczewski, A., Schmidt, W., & Rankin, J. G. (1977). Morbidity in alcoholics. Evidence for accelerated development of physical disease in women. Arch Intern Med, 137(7), 883-887.
Bataller, R., & Brenner, D. A. (2005). Liver fibrosis. J Clin Invest, 115(2), 209-218.
Becker, U., Deis, A., Sorensen, T. I., Gronbaek, M., Borch-Johnsen, K., Muller, C. F., . . . Jensen, G. (1996). Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology, 23(5), 1025-1029.
Becker, U., Gronbaek, M., Johansen, D., & Sorensen, T. I. (2002). Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology, 35(4), 868-875.
Bortolotti, F., Jara, P., Crivellaro, C., Hierro, L., Cadrobbi, P., Frauca, E., . . . Noventa, F. (1998). Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol, 29(2), 184-190.
Bosch, J., & Garcia-Pagan, J. C. (2000). Complications of cirrhosis. I. Portal hypertension. J Hepatol, 32(1 Suppl), 141-156.
Bouchier, I. A., Hislop, W. S., & Prescott, R. J. (1992). A prospective study of alcoholic liver disease and mortality. J Hepatol, 16(3), 290-297.
Butz, M., Timmermann, L., Braun, M., Groiss, S. J., Wojtecki, L., Ostrowski, S., . . . Schnitzler, A. (2010). Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy. Acta Neurol Scand, 122(1), 27-35.
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999). Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology, 29(3), 664-669.
Chan, H. L., Leung, N. W., Hussain, M., Wong, M. L., & Lok, A. S. (2000). Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology, 31(3), 763-768.
Chen, C. J., & Yang, H. I. (2011). Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol, 26(4), 628-638.
Chen, C. J., Yang, H. I., Su, J., Jen, C. L., You, S. L., Lu, S. N., . . . Iloeje, U. H. (2006). Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. Jama, 295(1), 65-73.
Chen, K. T., Chen, C. J., Fagot-Campagna, A., & Narayan, K. M. (2001). Tobacco, betel quid, alcohol, and illicit drug use among 13- to 35-year-olds in I-Lan, rural Taiwan: prevalence and risk factors. Am J Public Health, 91(7), 1130-1134.
Chen, Y. J., Chang, J. T., Liao, C. T., Wang, H. M., Yen, T. C., Chiu, C. C., . . . Cheng, A. J. (2008). Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci, 99(8), 1507-1514.
Chou, W. W., Guh, J. Y., Tsai, J. F., Hwang, C. C., Chen, H. C., Huang, J. S., Chuang, L. Y. (2008). Arecoline-induced growth arrest and p21WAF1 expression are dependent on p53 in rat hepatocytes. Toxicology, 243(1-2), 1-10. doi:10.1016/j.tox.2007.09.003
Corrao, G., Torchio, P., Zambon, A., D'Amicis, A., Lepore, A. R., & di Orio, F. (1998). Alcohol consumption and micronutrient intake as risk factors for liver cirrhosis: a case-control study. The Provincial Group for the study of Chronic Liver Disease. Ann Epidemiol, 8(3), 154-159.
Corrao, G., Torchio, P., Zambon, A., Ferrari, P., Arico, S., & di Orio, F. (1998). Exploring the combined action of lifetime alcohol intake and chronic hepatotropic virus infections on the risk of symptomatic liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in Italy. Eur J Epidemiol, 14(5), 447-456.
Corrao, G., Zambon, A., Torchio, P., Arico, S., La Vecchia, C., & di Orio, F. (1998). Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy. J Hepatol, 28(4), 608-614.
De Maria, N., Manno, M., & Villa, E. (2002). Sex hormones and liver cancer. Mol Cell Endocrinol, 193(1-2), 59-63.
del Olmo, J. A., Serra, M. A., Rodriguez, F., Escudero, A., Gilabert, S., & Rodrigo, J. M. (1998). Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis. J Cancer Res Clin Oncol, 124(10), 560-564.
Dela Cruz, A., Bugianesi, E., & George, J. (2014). Characteristics and long-term prognosis of lean patients with non-alcoholic fatty liver disease
S-909. Gastroenterology, 146:(5), S909.
Du, C. L., & Wang, J. D. (1998). Increased morbidity odds ratio of primary liver cancer and cirrhosis of the liver among vinyl chloride monomer workers. Occup Environ Med, 55(8), 528-532.
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., . . . Reeves, H. L. (2014). Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. J Hepatol, 60(1), 110-117.
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004). Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology, 127(5 Suppl 1), S35-50.
Fletcher, L. M., Dixon, J. L., Purdie, D. M., Powell, L. W., & Crawford, D. H. (2002). Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology, 122(2), 281-289.
Friedman, S. L. (2003). Liver fibrosis -- from bench to bedside. J Hepatol, 38 Suppl 1, S38-53.
Garcia-Tsao, G., Abraldes, J. G., Berzigotti, A., & Bosch, J. (2017). Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology, 65(1), 310-335. doi:10.1002/hep.28906
Garg, A., Chaturvedi, P., & Gupta, P. C. (2014). A review of the systemic adverse effects of areca nut or betel nut. Indian J Med Paediatr Oncol, 35(1), 3-9.
Giannitrapani, L., Soresi, M., La Spada, E., Cervello, M., D'Alessandro, N., & Montalto, G. (2006). Sex hormones and risk of liver tumor. Ann N Y Acad Sci, 1089, 228-236.
Glassner, A., Eisenhardt, M., Kramer, B., Korner, C., Coenen, M., Sauerbruch, T., . . . Nattermann, J. (2012). NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner. Lab Invest, 92(7), 967-977.
Guido, M., Fagiuoli, S., Tessari, G., Burra, P., Leandro, G., Boccagni, P., . . . Rugge, M. (2002). Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut, 50(5), 697-700.
Gur, C., Doron, S., Kfir-Erenfeld, S., Horwitz, E., Abu-Tair, L., Safadi, R., & Mandelboim, O. (2012). NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut, 61(6), 885-893.
Harrison, S. A. (2006). Liver disease in patients with diabetes mellitus. J Clin Gastroenterol, 40(1), 68-76.
Hsiao, T. J., Liao, H. W., Hsieh, P. S., & Wong, R. H. (2007). Risk of betel quid chewing on the development of liver cirrhosis: a community-based case-control study. Ann Epidemiol, 17(6), 479-485.
Hsu, Y. S., Chien, R. N., Yeh, C. T., Sheen, I. S., Chiou, H. Y., Chu, C. M., & Liaw, Y. F. (2002). Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology, 35(6), 1522-1527.
Hung, T. H., Liang, C. M., Hsu, C. N., Tai, W. C., Tsai, K. L., Ku, M. K., . . . Chuah, S. K. (2017). Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan. PLoS One, 12(7), e0181858.
Jacobson, I. M., Davis, G. L., El-Serag, H., Negro, F., & Trepo, C. (2010). Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol, 8(11), 924-933; quiz e117.
Keng, V. W., Largaespada, D. A., & Villanueva, A. (2012). Why men are at higher risk for hepatocellular carcinoma? J Hepatol, 57(2), 453-454.
Khan, I., Pant, I., Narra, S., Radhesh, R., Ranganathan, K., Rao, S. G., & Kondaiah, P. (2015). Epithelial atrophy in oral submucous fibrosis is mediated by copper (II) and arecoline of areca nut. J Cell Mol Med, 19(10), 2397-2412.
Ko, Y. C., Chiang, T. A., Chang, S. J., & Hsieh, S. F. (1992). Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med, 21(6), 261-264.
Kondili, L. A., Tosti, M. E., Szklo, M., Costantino, A., Cotichini, R., Resuli, B., . . . Mele, A. (1998). The relationships of chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and delta virus infection: a case-control study in Albania. Epidemiol Infect, 121(2), 391-395.
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., . . . Lowe, S. W. (2008). Senescence of activated stellate cells limits liver fibrosis. Cell, 134(4), 657-667.
Law, M. G. (1999). Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group. J Gastroenterol Hepatol, 14(11), 1100-1107.
Lee, C. H., Lee, J. M., Wu, D. C., Hsu, H. K., Kao, E. L., Huang, H. L., . . . Wu, M. T. (2005). Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer, 113(3), 475-482.
Liaw, Y. F., Tai, D. I., Chu, C. M., & Chen, T. J. (1988). The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology, 8(3), 493-496.
Lin, C. F., Shiau, T. J., Ko, Y. C., Chen, P. H., & Wang, J. D. (2008). Prevalence and determinants of biochemical dysfunction of the liver in Atayal Aboriginal community of Taiwan: is betel nut chewing a risk factor? BMC Gastroenterol, 8, 13. doi:10.1186/1471-230x-8-13
Lin, H. H., Wang, L. Y., Shaw, C. K., Cheng, M. L., Chung, W. K., Chiang, H. J., . . . Chen, C. J. (2002). Combined effects of chronic hepatitis virus infections and substance-use habits on chronic liver diseases in Taiwanese aborigines. J Formos Med Assoc, 101(12), 826-834.
Lin, Y. T., Wu, P. H., Lin, C. Y., Lin, M. Y., Chuang, H. Y., Huang, J. F., . . . Chuang, W. L. (2014). Cirrhosis as a risk factor for tuberculosis infection--a nationwide longitudinal study in Taiwan. Am J Epidemiol, 180(1), 103-110.
Lu, C. T., Yen, Y. Y., Ho, C. S., Ko, Y. C., Tsai, C. C., Hsieh, C. C., & Lan, S. J. (1996). A case-control study of oral cancer in Changhua County, Taiwan. J Oral Pathol Med, 25(5), 245-248.
Male, V., Stegmann, K. A., Easom, N. J., & Maini, M. K. (2017). Natural Killer Cells in Liver Disease. Semin Liver Dis, 37(3), 198-209.
Marengo, A., Jouness, R. I., & Bugianesi, E. (2016). Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults. Clin Liver Dis, 20(2), 313-324.
Melhem, A., Muhanna, N., Bishara, A., Alvarez, C. E., Ilan, Y., Bishara, T., . . . Safadi, R. (2006). Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol, 45(1), 60-71.
Mikolasevic, I., Milic, S., Turk Wensveen, T., Grgic, I., Jakopcic, I., Stimac, D., . . . Orlic, L. (2016). Nonalcoholic fatty liver disease - A multisystem disease? World J Gastroenterol, 22(43), 9488-9505.
Ministry of Health and Welfare. (2016). 2015 statistics of causes of death in Taiwan. Retrieved from https://www.mohw.gov.tw/lp-3265-2.html
Morgan, M. Y., & Sherlock, S. (1977). Sex-related differences among 100 patients with alcoholic liver disease. Br Med J, 1(6066), 939-941.
Muhanna, N., Abu Tair, L., Doron, S., Amer, J., Azzeh, M., Mahamid, M., . . . Safadi, R. (2011). Amelioration of hepatic fibrosis by NK cell activation. Gut, 60(1), 90-98.
Muir, A. J. (2000). The natural history of hepatitis C viral infection. Semin Gastrointest Dis, 11(2), 54-61.
Muretto, P., Angelucci, E., & Lucarelli, G. (2002). Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation. Ann Intern Med, 136(9), 667-672.
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007). Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science, 317(5834), 121-124.
Norton, S. A. (1998). Betel: consumption and consequences. J Am Acad Dermatol, 38(1), 81-88.
Petti, S. (2009). Lifestyle risk factors for oral cancer. Oral Oncol, 45(4-5), 340-350.
Radaeva, S., Sun, R., Jaruga, B., Nguyen, V. T., Tian, Z., & Gao, B. (2006). Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology, 130(2), 435-452.
Radaeva, S., Wang, L., Radaev, S., Jeong, W. I., Park, O., & Gao, B. (2007). Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. Am J Physiol Gastrointest Liver Physiol, 293(4), G809-816.
Radulescu, D., Duncea, C., & Donca, V. (2004). Hepatic cirrhosis associated with arterial pulmonary hypertension. Rom J Gastroenterol, 13(4), 341-343.
Sarma, A. B., Chakrabarti, J., Chakrabarti, A., Banerjee, T. S., Roy, D., Mukherjee, D., & Mukherjee, A. (1992). Evaluation of pan masala for toxic effects on liver and other organs. Food Chem Toxicol, 30(2), 161-163.
Sharan, R. N., & Choudhury, Y. (2010). Betel nut and susceptibility to cancer Environmental Factors, Genes, and the Development of Human Cancers (pp. 401-428): Springer.
Sherlock, S., Dooley, J., Sherlock, S., & Dooley, J. (2002a). Hepatic cirrhosis Diseases of the Liver and Biliary System. 11th ed. (pp. 365-380). London: Willy Blackwell.
Sherlock, S., Dooley, J., Sherlock, S., & Dooley, J. (2002b). Malignant liver tumors Diseases of the Liver and Biliary System. 11th ed. (pp. 537-562). London Willy Blackwell.
Singh, A., & Rao, A. R. (1995). Evaluation of the modifying influence of arecanut on the garlic-modulated hepatic detoxication system enzymes, sulfhydryl content, and lipid peroxidation in mice. Teratog Carcinog Mutagen, 15(3), 127-134.
Tanaka, K., Sakai, H., Hashizume, M., & Hirohata, T. (1998). A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis. Jpn J Cancer Res, 89(12), 1241-1250.
Tryc, A. B., Goldbecker, A., Berding, G., Rumke, S., Afshar, K., Shahrezaei, G. H., . . . Weissenborn, K. (2013). Cirrhosis-related Parkinsonism: prevalence, mechanisms and response to treatments. J Hepatol, 58(4), 698-705.
Tsai, J. F., Chang, W. Y., Jeng, J. E., Ho, M. S., Lin, Z. Y., & Tsai, J. H. (1994). Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver, 14(2), 98-102.
Tsai, J. F., Chang, W. Y., Jeng, J. E., Ho, M. S., Wang, L. Y., Hsieh, M. Y., . . . Tsai, J. H. (1993). Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol, 41(4), 296-300.
Tsai, J. F., Chuang, L. Y., Jeng, J. E., Ho, M. S., Hsieh, M. Y., Lin, Z. Y., & Wang, L. Y. (2001). Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study. Br J Cancer, 84(5), 709-713.
Tsai, J. F., Jeng, J. E., Chuang, L. Y., Ho, M. S., Ko, Y. C., Lin, Z. Y., . . . Dai, C. Y. (2004). Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine (Baltimore), 83(3), 176-187.
Tsai, J. F., Jeng, J. E., Chuang, L. Y., Ho, M. S., Ko, Y. C., Lin, Z. Y., . . . Ho, C. (2003). Habitual betel quid chewing as a risk factor for cirrhosis: a case-control study. Medicine (Baltimore), 82(5), 365-372.
Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., & Tsai, J. H. (1996). Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br J Cancer, 73(12), 1498-1502.
Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., & Tsai, J. H. (1997). Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer, 76(7), 968-974.
Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Lin, Z. Y., & Tsai, J. H. (1994). Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int J Cancer, 56(5), 619-621.
Wu, G. H., Boucher, B. J., Chiu, Y. H., Liao, C. S., & Chen, T. H. (2009). Impact of chewing betel-nut (Areca catechu) on liver cirrhosis and hepatocellular carcinoma: a population-based study from an area with a high prevalence of hepatitis B and C infections. Public Health Nutr, 12(1), 129-135.
Wu, M. T., Lee, Y. C., Chen, C. J., Yang, P. W., Lee, C. J., Wu, D. C., . . . Lee, J. M. (2001). Risk of betel chewing for oesophageal cancer in Taiwan. Br J Cancer, 85(5),
Xiao, R. M., Wang, J. J., Chen, J. Y., Sun, L. J., & Chen, Y. (2014). Effects of arecoline on hepatic cytochrome P450 activity and oxidative stress. J Toxicol Sci, 39(4), 609-614.
Xu, Z., Huang, C. M., Shao, Z., Zhao, X. P., Wang, M., Yan, T. L., . . . Shang, Z. J. (2017). Autophagy Induced by Areca Nut Extract Contributes to Decreasing Cisplatin Toxicity in Oral Squamous Cell Carcinoma Cells: Roles of Reactive Oxygen Species/AMPK Signaling. Int J Mol Sci, 18(3).
Zdrojewicz, Z., Kosowski, W., Krolikowska, N., Stebnicki, M., & Stebnicki, M. R. (2015). [Betel - the fourth most popular substance in the world]. Pol Merkur Lekarski, 39(231), 181-185.

 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top